Skip to content
Home/Companies/Healthcare/Oxford Drug Design
Oxford Drug Design

Oxford Drug Design

Healthcare·UK·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Oxford Drug Design?

Oxford Drug Design is currently owned by ACF Investors through Angel CoFund (2011 vintage), since 2019.

Hand-verified · updated 2026-04-21

ACF Investors
Investor
ACF Investors
Angel CoFund · 2011 · VC

Key facts

HQUK
SectorHealthcare
Websiteoxforddrugdesign.com

More from Angel CoFund

Other portfolio companies in the same fund.

Atelerix
Atelerix
Active
HealthcareUK· 2025
FLIT
Active
TMTUK· 2025
Hammer Missions
Hammer Missions
Active
SoftwareUK· 2025
Monument Therapeutics
Active
HealthcareUK· 2025
Teal Connect Ltd
Active
TMTUK· 2025
Arrow Risk Management
Arrow Risk Management
Active
FinancialsUK· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Oxford Drug Design

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Oxford Drug Design.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue